SMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NuScale Power (SMR) is not a good buy right now for a beginner long-term investor, despite the small upside in after-hours and some optimistic analyst targets. The stock is still technically weak, sentiment is mixed-to-bearish, insiders are selling aggressively, and there are lawsuit-related news risks. For an impatient investor, this is not a clean entry; I would not buy it today.
SMR is in a short-term bearish structure. The MACD histogram is negative and worsening, RSI_6 at 35.717 shows weak but not oversold momentum, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price closed at 9.85, just above S1 support at 9.771 and close to S2 at 9.24, while pivot resistance sits at 10.631. This suggests the stock is trading near support but with no confirmed reversal signal. The stock trend model suggests modest near-term upside, but that is not strong enough to override the broader weakness.
["Northland keeps an Outperform rating and still sees upside, with a $19 target.", "Analysts note progress on a potential 6 GW TVA-related deal, which could become a meaningful catalyst if execution advances.", "Options positioning leans toward calls, suggesting some traders remain optimistic.", "Stock pattern data suggests a possible modest rebound over the next week and month."]
["Kuehn Law is investigating a lawsuit tied to alleged misrepresentations about the ENTRA1 partnership.", "Insiders are selling heavily, with selling up 17090.48% over the last month.", "Citi is bearish with a Sell rating and a $7 target.", "Goldman Sachs lowered its target to $9 and remains Neutral.", "Multiple analyst targets were cut, showing fading confidence in the near-term execution story.", "Technical trend remains weak with bearish moving averages and negative MACD."]
No usable quarterly financial snapshot was provided because the financial data returned an error. As a result, I cannot confirm latest-quarter revenue or earnings growth trends, including the latest quarter season. Based on the available context, the market is still focused more on execution, deal progress, and dilution concerns than on proven financial improvement.
Analyst sentiment is mixed but trending lower in targets. Northland ($19, Outperform) and B. Riley ($19, Buy) remain constructive, but both lowered targets. HSBC initiated at Hold with a $13 target, while Goldman Sachs is Neutral at $9 and Citi is bearish at $7 with Sell ratings. Overall, Wall Street is split, but the recent direction is clearly cautious, with multiple target cuts and concern around execution and dilution.
